Showing results (151-160 of 198) with videos related to
Sort By:
Pageof 20
Cardiovascular Research|May 1, 1996
Infarct limitation of the second window of protection in a conscious rabbit modelX M Yang, G F Baxter, R J Heads, et al.Cardiovascular Research|January 1, 2000
Heat stress fails to protect myocardium of streptozotocin-induced diabetic rats against infarctionM Joyeux, P Faure, D Godin-Ribuot, et al.Circulation|June 27, 2001
Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxideM M Mocanu, H L Maddock, G F Baxter, et al.Journal of Molecular and Cellular Cardiology|November 1, 1987
Xanthine oxidase is not a source of free radicals in the ischemic rabbit heartJ M Downey, T Miura, L J Eddy, et al.Journal of the South African Veterinary Association|December 1, 1993
A serological survey of bovine brucellosis in the Molopo District of BophuthatswanaF R Bakunzi, G C Zyambo, S D MorrisCardiovascular Research|November 1, 1985
Infarct size limitation by the xanthine oxidase inhibitor, allopurinol, in closed-chest dogs with small infarctsS Akizuki, S Yoshida, D E Chambers, et al.Clinical and Experimental Dermatology|June 26, 2003
Persistent anticonvulsant hypersensitivity syndrome responding to ciclosporinK E Harman, S D Morris, E M HigginsBritish Journal of Pharmacology|July 19, 2006
Leptin, the obesity-associated hormone, exhibits direct cardioprotective effectsC C T Smith, M M Mocanu, S M Davidson, et al.Cardiovascular Drugs and Therapy|April 13, 2001
Adenosine A1 agonist at reperfusion trial (AART): results of a three-center, blinded, randomized, controlled experimental infarct studyG F Baxter, S L Hale, T Miki, et al.British Journal of Pharmacology|October 24, 2007
Erythropoietin protects the human myocardium against hypoxia/reoxygenation injury via phosphatidylinositol-3 kinase and ERK1/2 activationN R Mudalagiri, M M Mocanu, C Di Salvo, et al.Pageof 20